Search research articles
Contact Us
Filters
Showing results (241-250 of 306) with videos related to
Page
of 31
Sort By:
Therapeutic Advances in Medical Oncology
|
March 15, 2021
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial
Jakob M Riedl, Samantha O Hasenleithner, Gudrun Pregartner, et al.
Molecular Oncology
|
June 2, 2021
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary
Noemi Laprovitera, Mattia Riefolo, Elisa Porcellini, et al.
Cancers
|
July 2, 2021
Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing-A Prospective Feasibility Study
Marina Berger, Andrea Thueringer, Doritt Franz, et al.
Plos One
|
October 2, 2018
Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study
Georg Richtig, Christoph Hoeller, Martin Wolf, et al.
Oncoimmunology
|
February 9, 2018
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
Florian Posch, Karina Silina, Sebastian Leibl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 5, 2021
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis
Jakob M Riedl, Florian Posch, Lena Horvath, et al.
Cancer Research
|
October 16, 2016
Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells
Pinar Kanlikilicer, Mohammed H Rashed, Recep Bayraktar, et al.
Blood
|
February 21, 2014
NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas
Alexander J A Deutsch, Beate Rinner, Kerstin Wenzl, et al.
International Journal of Molecular Sciences
|
October 17, 2018
MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients
Angelika Terbuch, Jan B Adiprasito, Verena Stiegelbauer, et al.
Cancers
|
November 13, 2021
Seasonal Variations in the Diagnosis of Testicular Germ Cell Tumors: A National Cancer Registry Study in Austria
Gennadi Tulchiner, Nina Staudacher, Josef Fritz, et al.
Page
of 31
Search research articles
Search
Showing results (241-250 of 306) with videos related to
Sort By:
Page
of 31
Therapeutic Advances in Medical Oncology
|
March 15, 2021
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial
Jakob M Riedl, Samantha O Hasenleithner, Gudrun Pregartner, et al.
Molecular Oncology
|
June 2, 2021
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary
Noemi Laprovitera, Mattia Riefolo, Elisa Porcellini, et al.
Cancers
|
July 2, 2021
Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing-A Prospective Feasibility Study
Marina Berger, Andrea Thueringer, Doritt Franz, et al.
Plos One
|
October 2, 2018
Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study
Georg Richtig, Christoph Hoeller, Martin Wolf, et al.
Oncoimmunology
|
February 9, 2018
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
Florian Posch, Karina Silina, Sebastian Leibl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 5, 2021
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis
Jakob M Riedl, Florian Posch, Lena Horvath, et al.
Cancer Research
|
October 16, 2016
Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells
Pinar Kanlikilicer, Mohammed H Rashed, Recep Bayraktar, et al.
Blood
|
February 21, 2014
NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas
Alexander J A Deutsch, Beate Rinner, Kerstin Wenzl, et al.
International Journal of Molecular Sciences
|
October 17, 2018
MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients
Angelika Terbuch, Jan B Adiprasito, Verena Stiegelbauer, et al.
Cancers
|
November 13, 2021
Seasonal Variations in the Diagnosis of Testicular Germ Cell Tumors: A National Cancer Registry Study in Austria
Gennadi Tulchiner, Nina Staudacher, Josef Fritz, et al.
Page
of 31